357 related articles for article (PubMed ID: 31188674)
1. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
[TBL] [Abstract][Full Text] [Related]
2. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
[TBL] [Abstract][Full Text] [Related]
3. Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study.
Gao J; Huang X; Di W; Dong X; Gou W; Shi H; Wang Z; Dietl A; Grill S; Hund M
Front Cardiovasc Med; 2021; 8():602560. PubMed ID: 34497833
[TBL] [Abstract][Full Text] [Related]
4. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
[TBL] [Abstract][Full Text] [Related]
5. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
[TBL] [Abstract][Full Text] [Related]
8. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.
Dröge LA; Perschel FH; Stütz N; Gafron A; Frank L; Busjahn A; Henrich W; Verlohren S
Hypertension; 2021 Feb; 77(2):461-471. PubMed ID: 33280406
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: A prospective cohort study.
Hughes RCE; Phillips I; Florkowski CM; Gullam J
Aust N Z J Obstet Gynaecol; 2023 Feb; 63(1):34-41. PubMed ID: 35670085
[TBL] [Abstract][Full Text] [Related]
13. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
Andersen LLT; Helt A; Sperling L; Overgaard M
J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of the sFlt-1/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study.
Ohkuchi A; Masuyama H; Yamamoto T; Kikuchi T; Taguchi N; Wolf C; Saito S
Hypertens Res; 2021 Jul; 44(7):822-829. PubMed ID: 33594274
[TBL] [Abstract][Full Text] [Related]
15. sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective.
Hodel M; Blank PR; Marty P; Lapaire O
Dis Markers; 2019; 2019():4096847. PubMed ID: 31485276
[TBL] [Abstract][Full Text] [Related]
16. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
Schlembach D; Hund M; Schroer A; Wolf C
BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia.
Binder J; Palmrich P; Pateisky P; Kalafat E; Kuessel L; Zeisler H; Munkhbaatar M; Windsperger K; Thilaganathan B; Khalil A
Hypertension; 2020 Jul; 76(1):176-183. PubMed ID: 32450740
[TBL] [Abstract][Full Text] [Related]
18. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.
Yu F; Bai Q; Zhang S; Jiang Y
J Clin Lab Anal; 2019 Jun; 33(5):e22861. PubMed ID: 30758082
[TBL] [Abstract][Full Text] [Related]
20. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
